SCHEMBL1634289

SCHEMBL1634289

CN(Cc1cncc(-c2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)c1)C1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ MAPK10 P53779 6/20 0.42
▸ IKBKB O14920 3/20 0.40
▸ PTK2 Q05397 3/20 0.40
▸ NTRK1 P04629 3/20 0.39
▸ TBK1 Q9UHD2 2/20 0.39
▸ IKBKE Q14164 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ JUN P05412 4/20 0.38
▸ MAPK8 P45983 3/20 0.38
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ NUAK1 O60285 1/20 0.38
▸ STK16 O75716 1/20 0.38
▸ CSF1R P07333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632276 0.85 NTRK1 (0.42) MAPK10IKBKBPTK2NTRK1TBK1
SCHEMBL1634505 0.81 TBK1 (0.55) CDK1MAPK10IKBKBPTK2NTRK1
SCHEMBL1633768 0.78 PTK2 (0.45) CDK1CDK2CDK9MAPK10IKBKB
SCHEMBL1632155 0.77 IKBKB (0.46) CDK1CDK2CDK9MAPK10IKBKB
SCHEMBL1633524 0.77 JAK2 (0.50) IKBKBPTK2NTRK1TBK1JAK2
SCHEMBL1633715 0.75 NTRK1 (0.42) CDK1CDK2CDK9MAPK10IKBKB
SCHEMBL1633214 0.74 MAPK10 (0.50) CDK1CDK2CDK9MAPK10IKBKB
SCHEMBL1633433 0.74 MAPK10 (0.64) MAPK10NTRK1JAK2JUNMAPK8
SCHEMBL1633057 0.74 EGFR (0.51) CDK1CDK2CDK9MAPK10IKBKB
SCHEMBL13498247 0.74 IKBKB (0.44) CDK1CDK2CDK9IKBKBPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback